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Exposure to metals commonly found in the environment has been hypothesized to be associated with
measures of fetal growth but the epidemiological literature is limited. The Maternal–Infant Research on
Environmental Chemicals (MIREC) study recruited 2001 women during the ﬁrst trimester of pregnancy
from 10 Canadian sites. Our objective was to assess the association between prenatal exposure to metals
(lead, arsenic, cadmium, and mercury) and fetal metabolic function. Average maternal metal con-
centrations in 1st and 3rd trimester blood samples were used to represent prenatal metals exposure.
Leptin and adiponectin were measured in 1363 cord blood samples and served as markers of fetal
metabolic function. Polytomous logistic regression models were used to estimate odds ratios (OR) and
95% conﬁdence intervals (CI) for the association between metals and both high (Z90%) and low (r10%)
fetal adiponectin and leptin levels. Leptin levels were signiﬁcantly higher in female infants compared to
males. A signiﬁcant relationship between maternal blood cadmium and odds of high leptin was observed
among males but not females in adjusted models. When adjusting for birth weight z-score, lead was
associated with an increased odd of high leptin. No other signiﬁcant associations were found at the top or
bottom 10th percentile in either leptin or adiponectin models. This study supports the proposition that
maternal levels of cadmium inﬂuence cord blood adipokine levels in a sex-dependent manner. Further
investigation is required to conﬁrm these ﬁndings and to determine how such ﬁndings at birth will
translate into childhood anthropometric measures.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Early pregnancy is a critical window of fetal development and
exposure to environmental contaminants during this time period
may adversely impact the pregnancy as well as neonatal, early
childhood, and later life outcomes (Gluckman et al., 2008; Selevan
et al., 2000). Previous studies have suggested that prenatal ex-
posure to metals, such as lead, mercury, cadmium, and arsenic,Inc. This is an open access article u
Canada, St. Justine's Hospital
, NS). All study participants
rch Unit, 7th Floor Women's
ox 9700, Halifax, NS, Canadamay adversely affect fetal growth (Drouillet-Pinard et al., 2010;
Gundacker et al., 2010; Kippler et al., 2012; Lin et al., 2011; Menai
et al., 2012; Schell et al., 2009; Xie et al., 2013; Zhu et al., 2010).
Maternal exposure to lead, mercury, and arsenic creates direct
exposure to the developing fetus as these chemicals can pass
through the placenta into fetal circulation (Barr et al., 2007;
Klaasen, 2010; Needham et al., 2011). Cadmium, which does not
directly enter fetal circulation, can promote potentially adverse
effects on the fetus by accumulating in the placenta and altering
normal placental processes and function (Barr et al., 2007; Roels
et al., 1978). Studies in North American populations have demon-
strated that exposure is ubiquitous with the majority of women
having detectable concentrations of metals in their blood or urine
(Health Canada, 2010; NHANES, 2013). Epidemiologic literature is
suggestive of an inverse association between maternal exposure to
certain metals, particularly lead, and infant growth (Gonzalez-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2010), but longitudinal analyses in North American populations
without relatively high levels of exposure is limited.
Metabolic function can be examined by measuring leptin and
adiponectin levels in blood, two hormones produced by adipo-
cytes that play critical roles in metabolic function (Karakosta and
Chatzi, 2011; Trujillo and Scherer, 2005; Walsh et al., 2014).
Elevated levels of both leptin and adiponectin in umbilical cord
blood are correlated with high birth weight and may provide in-
sight on future risk of childhood obesity (Karakosta and Chatzi,
2011; Mantzoros et al., 2009). In adults, elevated leptin levels are
associated with increased adipose tissue mass, insulin resistance
(Mantzoros et al., 2009), and, in pregnant women having large for
gestational age infants (Retnakaran et al., 2012). In contrast, low
adiponectin levels in adulthood have been implicated in insulin
resistance, type 2 diabetes, and metabolic syndrome (Mazaki-Tovi
et al., 2005; Trujillo and Scherer, 2005). Examining the relation-
ship between maternal metal concentrations and biomarkers of
fetal metabolic function may provide insight into the susceptibility
of fetal metabolic development to exogenous in utero exposures.
The objectives of the present study were to assess the relationship
between maternal blood levels of lead, arsenic, cadmium, and
mercury and umbilical cord blood levels of leptin and adiponectin
among the cohort of mother–infants pairs enrolled in the Ma-
ternal–Infant Research on Environmental Chemicals (MIREC)
study.2. Material and methods
2.1. Study design
Details of the MIREC study have been previously reported
(Arbuckle, et al., 2013). Brieﬂy, 2001 women were recruited from
10 Canadian sites during their ﬁrst trimester and consented to
provide urine and blood samples. Women were eligible for in-
clusion if they were o14 weeks gestation at the time of recruit-
ment, Z18 years of age, able to communicate in French or English,
and planning on delivering at a local hospital. Women with known
fetal or chromosomal anomalies in the current pregnancy and
women with serious medical complications were excluded from
the study (Arbuckle et al., 2013). Of the 2001 women recruited into
the MIREC study, 18 withdrew and asked that all their data and
biospecimens be destroyed. Of the remaining 1983 subjects, 1363
had infants with a cord blood sample. For this analysis, 103 were
excluded for: multiple birth, pre-term birth, cord blood samples
unsuitable for analysis, missing metal data or unknown infant sex,
resulting in an analytical sample size of 1260.
2.2. Metal exposure
Chemical analysis of blood samples were carried out at the
Laboratoire de Toxicologie, Institut National de Santé Publique
du Québec (INSPQ) (Québec, QC, Canada), accredited by the
Standards Council of Canada. Lead, arsenic, mercury, and cad-
mium were measured in maternal whole blood collected during
the 1st and 3rd trimesters using inductively coupled plasma mass
spectrometry (PerkinElmer ELAN ICP-MS DRC II). Metal con-
centrations from the two time points were averaged to create an
estimate of gestational exposure. In the case where the value for
one time point was missing, the other value was used. All samples
below the level of detection (LOD) were imputed as one half the
level of detection. We also conducted an analysis to determine
whether samples collected in the third trimester would have a
different inﬂuence on results compared to the ﬁrst trimester
measurements.2.3. Fetal markers of metabolic function
Leptin and adiponectin were measured in plasma from 1363
stored umbilical cord blood samples by ELISA using kits fromMeso
Scale Discovery (MSD) (Rockville, MD, USA) at Mt. Sinai Laboratory
(Toronto, ON, Canada). Repeated analysis was performed on all
samples with a coefﬁcient of variation (CV) greater than 15%. The
inter- and intra-assay CVs, respectively, were 11.8% and 9.3% for
leptin and 8% and 9% for adiponectin. All samples were above the
limit of detection.
2.4. Covariates
Data on covariates were extracted from questionnaires and
hospital charts by trained research staff. We examined the fol-
lowing variables as potential confounders: maternal age at deliv-
ery (r24, 25–29, 30–34, Z35 years), pre-pregnancy body mass
index (BMI) according to WHO guidelines (World Health Organi-
zation, 2006), parity (nulliparous, parous), maternal education
(high school diploma or less, some college or trade school, un-
dergraduate university degree, graduate university degree),
household income ($r30,000, 30,001–50,000, 50,001–100,000,
Z100,000), ethnicity (Caucasian/non-Caucasian), and maternal
smoking (never or quit before pregnancy, quit when pregnancy
conﬁrmed, current smoker).
2.5. Statistical analysis
Umbilical cord blood levels of leptin and adiponectin were
categorized into the 10th and 90th percentiles, as the previous
literature has shown that both low and high levels of both of these
biomarkers are associated with potentially adverse outcomes
(Mantzoros et al., 2009; Trujillo and Scherer, 2005; Walsh et al.,
2014). Due to differing leptin levels between male and female
infants, the binary leptin variables were derived using sex speciﬁc
cut-off points: 10th percentile (males 1.8, females 3.5 ng/mL) and
90th percentile (males 31.2, females 54.6 ng/mL). Adiponectin
levels did not vary by sex, thus, sex-speciﬁc cut-offs were not
necessary.
Descriptive statistics for maternal demographics, weight-re-
lated characteristics, and pregnancy characteristics were calcu-
lated according to levels of leptin and adiponectin using frequency
distributions and chi-square tests of signiﬁcance for the difference
between the low (r10%ile), moderate (410–o90%) and elevated
(Z90%ile) leptin and adiponectin groups.
The geometric means (GM) and standard deviations (SD) of the
metals according to the outcome categories of leptin and adipo-
nectin were determined. Separate models were developed for
leptin and adiponectin using polytomous regression to examine
the odds of both high (Z90%) and low (r10%) levels of the
markers of metabolic function. Polytomous logistic regression is an
extension of simple logistic regression that facilitates analysis of
multinomial outcomes (Ananth and Kleinbaum, 1997). The cut-off
points in the present study were selected to capture infants with
elevated and suppressed adipokine values. But, in recognition of
the fact that the choice of these cut-off points was somewhat ar-
bitrary, we conducted a sensitivity analysis to examine the out-
come categories at the 25th and 75th percentiles.
Next, metals were categorized in quartiles and, since no metal
had more than 25% below the LOD, all levels below LOD were
included in the lowest quartile for each metal. Due to the lack of
linearity in quartile association estimates, we did not examine the
chemical exposures as continuous variables. In the multivariate
models, we included variables that were selected a priori
(maternal age) or signiﬁcantly associated with the adipokines at a
p-value o0.1 in order to facilitate identiﬁcation of a common set
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tween infant sex and metal exposure was assessed in each model
using the likelihood ratio test to determine if model ﬁt improved
with the inclusion of the product term. Results were stratiﬁed by
sex if the likelihood ratio test was signiﬁcant at po0.1. In addition,
in order to determine whether any association we observed be-
tween metals and leptin or adioponectin were independent of
fetal fat mass, we conducted an analysis adjusting for birth z-score
(as a surrogate of fat mass).
For metals with signiﬁcant associations in either the main or
sensitivity analysis, we produced locally weighted scatterplot
smoothing (LOESS) plots to facilitate visualization of associations
observed in the categorical analyses. The smoothing criterion for
the displayed plots was selected as the value that would minimize
the corrected Akaike's information criterion (AIC).
All analyses were done completed using SAS v.9.2 (SAS In-
stitute, Inc., Cary, NC, USA). This study received ethical approval
from the IWK Health Centre (Halifax, NS), Health Canada, and Ste.
Justine's Hospital (Montreal, QC).3. Results
Median (IQR) leptin concentrations were signiﬁcantly higher
among female infants (16.0 (26.3) ng/mL) than in males (8.7
(13.6) ng/mL) and ranged from 0.086 to 243 ng/mL. Median adi-
ponectin concentrations did not differ by sex (males 16.7 (12.7),
females 16.7 (12.6) μg/mL) and ranged from 0.19 to 239 μg/mL.
The Pearson correlation coefﬁcient between leptin and adipo-
nectin levels was 0.45 among males and 0.53 among females.
The majority of study participants were over 30 years of age at
the time of pregnancy, were of normal BMI, were university edu-
cated, had a household income greater than $50,000, never
smoked and were Caucasian (Table 1).
The geometric mean (SD) levels of the average of ﬁrst and third
trimester metals are as follows: lead¼0.88 (1.61) mg/dL, arsenic¼1.14
(1.98) mg/L, mercury¼0.86 (2.84) mg/L, and cadmium¼0.32 (2.13) mg/
L. The Pearson correlation coefﬁcient for the ﬁrst and third trimester
blood metal levels as follows: lead¼0.70, arsenic¼0.36, cadmium¼
0.60, mercury¼0.75 (Pearson correlation coefﬁcient). Geometric
means according to high and low levels of leptin and adiponectin are
presented in Table 2.
Multivariate models assessing the association between metals
and leptin were adjusted for maternal age, pre-pregnancy BMI,
and parity. The adiponectin models were adjusted for age and
education. No statistically signiﬁcant associations were observed
between lead, arsenic or mercury and either low or high leptin
levels (Table 3). Adjustment for birth weight z-score resulted in an
elevated, borderline signiﬁcant odds ratio of elevated leptin in the
fourth quartile of maternal lead levels (OR¼1.7 95% CI: 1.0–2.9)
(Table 3). Effect modiﬁcation by sex was observed in the re-
lationship between cadmium and leptin levels (p-valueo0.1). The
highest quartile of maternal blood cadmium was associated with a
signiﬁcantly increased risk of high (Z90%) leptin (OR¼4.3, 95% CI:
1.8–10.0) among males in the adjusted model (Table 4). There
were no signiﬁcant associations between any of the metals and
adiponectin in crude or adjusted analyses (Table 5).
In sensitivity analyses, the highest quartile of maternal cad-
mium was associated with increased odds of high (Z75%) leptin
(aOR¼1.7, 95% CI: 1.0–2.9) in males. No signiﬁcant associations
were observed between cadmium and leptin in females or be-
tween leptin and lead, mercury or arsenic. No signiﬁcant asso-
ciations were observed between any of the metals and adiponectin
in the sensitivity analysis using the upper and lower 25%ile of
adiponectin. All results using third trimester measurementscompared to ﬁrst trimester measurements were similar in mag-
nitude and statistical signiﬁcance.
Fig. 1 and 2 depict LOESS curves for the associations between
leptin and cadmium (males only) and lead. The smoothing para-
meter was set to 0.471 and 0.998 in the lead and cadmium plots
respectively as these values were associated with a minimal AIC
value. Fig. 1 depicts the association between cadmium and leptin,
demonstrating a trend towards increasing leptin levels at high
maternal cadmium concentrations for male infants. Fig. 2 depicts
the association between lead and leptin, showing a non-linear
relationship between lead and leptin that plateaus at the highest
concentrations.4. Discussion
In this analysis of the association between maternal blood le-
vels of metals and cord blood levels of leptin and adiponectin, we
observed that elevated maternal blood concentrations of cadmium
were signiﬁcantly associated with high cord blood leptin levels
among their male infants. An analysis based on continuous mea-
sures of leptin showed a similar association with cadmium levels,
and suggests that leptin increases only at the higher cadmium
levels within this population. On average, the maternal level of
cadmium exposure (median level¼0.28 mg/L) in MIREC partici-
pants was well below the intervention level of 5 mg/L deﬁned by
OSHA (2004). Only a limited number of participants had cadmium
exposure levels that approached this cut-off value. Our ﬁnding
suggests that maternal cadmium concentrations substantially
lower than the cut-off value (the 4th quartile cut-off was 0.44 mg/
L) are associated with elevated cord blood leptin levels in males.
No signiﬁcant associations were observed between leptin and
cadmium among females, nor did we observe any statistically
signiﬁcant associations between maternal metal levels and either
low or high adiponectin.
While there have been no epidemiological studies examining
the relationship between cadmium and cord blood leptin con-
centrations, there is evidence from the toxicology literature that
placental cadmium concentrations are associated with decreased
placental leptin synthesis (Stasenko et al., 2010) and that leptin
and adiponectin expression is reduced in response to cadmium
exposure (Kawakami et al., 2013). A Bangladeshi cohort study re-
ported a signiﬁcant inverse association between maternal blood
cadmium levels (median¼0.63 mg/L) and birth weight among girls
but not boys (Kippler et al., 2012), inverse association between
maternal cadmium blood levels (median¼0.8 mg/L) and birth
weight was observed among smokers, but not non-smokers, in a
French birth cohort. Results were not stratiﬁed by sex in this study
(Menai et al., 2012). A Taiwanese birth cohort study reported a
signiﬁcant inverse association between cord blood, but not ma-
ternal (median¼1.05 mg/L), cadmium and head circumference at
birth. Associations between both cord blood and maternal cad-
mium levels were inversely yet not signiﬁcantly associated with
other growth parameters at birth (Lin et al., 2011). The inverse
association between cadmium and fetal growth may be explained
by the fact that cadmium has been shown to interfere with the
placental transfer of micronutrients such as zinc to the fetus
(Kippler et al., 2010). This explanation is consistent with evidence
that cadmium accumulates in the placenta and that cord blood
levels have been shown to be lower than maternal blood levels
(Barr et al., 2007; Kuhnert et al., 1982).
In light of this previous research and evidence that fetal
cadmium exposure is mitigated by the placenta, the observed
ﬁnding of a signiﬁcant association between relatively low ma-
ternal cadmium levels and elevated cord blood leptin concentra-
tions among males is novel and warrants further investigation.
Table 1
Maternal demographic characteristics according to cord blood levels of leptin (ng/mL) and adiponectin (mg/mL). (MIREC study, 2008-2011).
Characteristic N Leptin (row %) Adiponectin (row %)
r10% 10–90% Z90% p-Value r10% 10-90% Z90% p-Value
Maternal age
r24 60 13.3 80.0 6.7 0.73 10.0 80.0 10.0 0.90
25–29 270 10.0 77.8 12.2 10.7 77.8 11.5
30–34 451 8.0 83.4 8.7 10.0 80.7 9.3
Z35 479 11.7 78.1 10.2 10.0 80.0 10.0
Pre-pregnancy BMI
Underweight (o18.5) 27 22.2 70.4 7.4 o0.01 22.2 70.4 7.4 0.28
Normal (18.5–24.9) 720 13.0 79.6 7.5 11.1 78.6 10.3
Overweight (25–29.9) 272 4.0 83.8 12.1 8.8 80.5 10.7
Obese (Z30) 171 6.4 76.0 17.5 8.2 83.0 8.8
Missing 70
Parity
Nulliparous 529 9.3 76.9 13.8 o0.01 9.3 79.6 11.2 0.19
Parous 729 10.7 82.2 7.1 10.8 79.8 9.3
Missing 2
Education
High school diploma or less 105 10.5 79.1 10.5 0.71 10.5 81.0 8.6 0.10
Some college, or trade school 362 10.8 77.1 12.2 11.9 79.0 9.1
Undergraduate university degree 480 10.0 81.5 8.5 9.6 80.6 9.8
Graduate university degree 311 9.3 81.4 9.3 9.0 78.8 12.2
Missing 2
Household Income ($CAD)
r30,000 91 14.3 74.7 11.0 0.80 13.2 78.0 8.8 0.36
30,001–50,000 116 5.2 84.5 10.3 7.8 84.5 7.8
50,001–100,000 516 10.9 77.9 11.2 11.1 77.5 11.4
Z100,000 488 9.2 82.2 8.6 8.6 81.8 9.6
Missing 49
Ethnicity
Caucasian 1087 9.8 80.4 9.8 0.89 10.6 78.7 10.8 0.60
Not Caucasian 173 11.6 77.5 11.0 7.5 86.7 5.8
Maternal smoking
Never or quit before pregnancy 1109 10.1 80.6 9.3 0.23 10.1 79.8 10.1 0.78
Quit when pregnancy conﬁrmed 90 8.9 76.7 14.4 12.2 80.0 7.8
Current smoker 61 11.5 73.8 14.8 8.2 78.7 13.1
Infant sex
Male 675 10.1 80.0 9.9 0.99 9.6 81.6 8.8 0.50
Female 585 10.1 80.0 9.9 10.8 77.7 11.6
Cord blood adiponectin (μg/mL)
r10% 123 43.8 50.0 6.3 o0.01 – – – –
10–90% 1005 6.8 84.4 8.9
Z90% 127 2.4 75.6 22.1
Cord blood leptin (ng/mL)
r10% 127 – – – – 44.1 53.5 2.4 o0.01
o90% 1008 6.6 84.1 9.5
Z90% 125 6.4 71.2 22.4
Table 2
Geometric mean blood concentration of metals according to categories of cord leptin (ng/mL) and adiponectin (mg/mL) (MIREC study, 2008–2011) (n¼1260).
Metal % 4LODa Leptin Adiponectin
r10% 10–90% Z90% r10% 10–90% Z90%
Lead (mg/dL) 100 0.89 (1.61) 0.88 (1.61) 0.93 (1.65) 0.88 (1.61) 0.89 (1.61) 0.86(1.63)
Mercury (mg/L) 90.6 0.93 (2.93) 0.87 (2.85) 0.74 (2.69) 0.86 (2.88) 0.86 (2.82) 0.83 (3.00)
Arsenic (mg/L) 93.6 1.11 (2.13) 1.15 (1.95) 1.10 (2.04) 1.14 (2.11) 1.14 (1.94) 1.17 (2.14)
Cadmium (mg/L) 97.4 0.32 (2.22) 0.31 (2.07) 0.36 (2.50) 0.30 (2.04) 0.32 (2.15) 0.31 (2.10)
a % 4LOD based on ﬁrst trimester measurements (lead¼0.1 mg/dL, mercury¼0.12 mg/L, arsenic¼0.22 mg/L, cadmium¼0.04 mg/L)
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Table 3
Odds ratio of high (Z90%) and low (r10%) leptin (ng/mL) and prenatal exposure to quartiles of maternal blood metals (MIREC study, 2008–2011) (n¼1188).
Contaminant Low leptin High leptin
Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95% CI) Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95% CI)
Lead (mg/dL)
r0.63 1.0 1.0 1.0 1.0 1.0 1.0
0.64 to r0.87 1.1 (0.6–1.8) 1.1 (0.6–1.8) 0.9 (0.5–1.6) 1.1 (0.6–1.8) 1.1 (0.6–1.9) 1.2 (0.7–2.1)
0.88 to r1.20 0.8 (0.4–1.3) 0.7 (0.4–1.3) 0.6 (0.3–1.1) 0.8 (0.4–1.3) 0.9 (0.5–1.6) 1.0 (0.6–1.8)
41.20 1.3 (0.8–2.2) 1.2 (0.7–2.0) 0.9 (0.5–1.5) 1.3 (0.8–2.1) 1.4 (0.8–2.3) 1.7 (1.0–2.9)
Arsenic (mg/L)
r0.77 1.0 1.0 1.0 1.0 1.0 1.0
0.78 to r1.13 0.9 (0.6–1.6) 1.0 (0.6–1.6) 1.0 (0.6–1.8) 1.0 (0.6–1.7) 1.0 (0.6–1.6) 1.0 (0.6–1.8)
1.14 to r1.72 0.6 (0.3–1.0) 0.6 (0.3–1.0) 0.6 (0.3–1.1) 0.8 (0.5–1.4) 0.8 (0.5–1.3) 0.8 (0.5–1.5)
41.72 1.0 (0.6–1.6) 0.9 (0.5–1.5) 0.9 (0.5–1.5) 0.8 (0.5–1.4) 0.8 (0.5–1.4) 0.9 (0.5–1.6)
Mercury (mg/L)
r0.46 1.0 1.0 1.0 1.0 1.0 1.0
0.47 to r0.99 1.0 (0.6–1.7) 0.9 (0.5–1.5) 1.0 (0.5–1.7) 1.3 (0.8–2.1) 1.4 (0.8–2.3) 1.4 (0.8–2.5)
1.0 to r1.86 1.1 (0.6–1.8) 0.9 (0.5–1.5) 0.8 (0.5–1.5) 0.9 (0.5–1.5) 0.8 (0.5–1.5) 0.9 (0.5–1.6)
41.86 0.9 (0.5–1.5) 0.7 (0.4–1.2) 0.6 (0.3–1.1) 0.7 (0.4–1.3) 0.7 (0.4–1.3) 0.8 (0.4–1.4)
a Adjusted for maternal age, parity, pre-pregnancy BMI.
b Adjusted for maternal age, parity, pre-pregnancy BMI, birth weight z-score.
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cadmium and cord blood leptin levels, however, is consistent with
evidence that cadmium exposure has been shown to have a sex-
speciﬁc effect on DNA methylation. Methylated sites in girls were
associated with organ development changes where those changes
observed in boys were found in cell death (Kippler et al., 2013).
The sex-dependent nature of cadmium related effects is hy-
pothesized to be due to its estrogenic properties (Garcia-Morales
et al., 1994; Henson and Chedrese, 2004; Johnson et al., 2003).
Moreover, it is worth noting that though smoking is a known
source of exposure to cadmium, this variable was not identiﬁed as
a confounder in the present analysis and, therefore, not included
in our statistical models. The lack of inﬂuence of smoking on the
associations between cadmium and cord blood cytokine levels
may be due to the low smoking rates among MIREC study
participants.
Though no identiﬁed literature has examined the association
between prenatal lead exposure and leptin levels, epidemiological
studies have reported an inverse relationship between lead and
newborn growth (Gonzalez-Cossio et al., 1997; Schell et al., 2009;Table 4
Odds ratio of high (Z90%) and low (r10%) leptin (ng/mL) and prenatal exposure to qua
(n¼1188).
Contaminant Low leptin
Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95%
Cadmium (lg/L)
Males (n¼639)
r0.20 1.0 1.0 1.0
0.21 to r0.29 1.0 (0.5–2.0) 1.0 (0.5–2.0) 1.0 (0.5–2.1)
0.30 to r0.44 0.7 (0.3–1.4) 0.7 (0.3–1.4) 0.7 (0.3–1.5)
40.44 1.0 (0.5–2.1) 1.0 (0.5–2.0) 0.9 (0.4–2.0)
Females (n¼549)
r0.20 1.0 1.0 1.0
0.21 to r0.29 1.8 (0.8–3.9) 1.7 (0.8–3.9) 1.7 (0.7–3.8)
0.30 to r0.43 1.0 (0.4–2.4) 0.9 (0.4–2.1) 0.8 (0.3–2.1)
40.43 1.6 (0.7–3.6) 1.5 (0.7–3.5) 1.2 (0.5–2.9)
a Adjusted for maternal age, parity, pre-pregnancy BMI.
b adjusted for maternal age, parity, pre-pregnancy BMI, birth weight z-score.Xie et al., 2013; Zhu et al., 2010). Inverse associations between
maternal lead levels and birth weight have been observed in birth
cohort studies from NY state (Schell et al., 2009; Zhu et al., 2010),
Mexico (Gonzalez-Cossio et al., 1997), and China (Xie et al., 2013).
The median level of maternal blood lead in these studies was 3 mg/
dL in the New York state birth cohort (selected based on risk
factors for lead exposure, namely poverty and residence in older,
poorly maintained housing) (Schell et al., 2009), 3.2 mg/dL in the
Chinese birth cohort (Xie et al., 2013), and 2 mg/dL in a birth cohort
from NY study using data from metals registry (Zhu et al., 2010).
The Mexican cohort examined tibial bone lead levels (Gonzalez-
Cossio et al., 1997). The observed inverse associations between
maternal lead levels and birth weight may be explained by lead
interference with calcium transport and function (Bellinger, 2005;
Pounds, 1984). We observed that the highest quartile of lead ex-
posure was associated with increased odds of elevated leptin after
adjustment for birth weight z-score. This ﬁnding, which warrants
further investigation, raises interesting questions regarding the
role of lead in fetal growth. On the one hand, previous research has
demonstrated that lead is inversely related to growth, particularlyrtiles of maternal blood cadmium, stratiﬁed by infant sex (MIREC study, 2008–2011)
High leptin
CI) Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95% CI)
1.0 1.0 1.0
2.1 (0.9–5.1) 2.3 (0.9–5.7) 2.4 (0.9–6.0)
1.9 (0.8–4.6) 2.2 (0.9–5.4) 2.4 (0.9–6.0)
3.9 (1.7–8.8) 4.3 (1.8–10.0) 4.5 (1.9–10.8)
1.0 1.0 1.0
1.2 (0.6–2.4) 1.2 (0.6–2.6) 1.2 (0.6–2.6)
0.7 (0.3–1.6) 0.8 (0.3–1.7) 0.8 (0.3–1.7)
0.8 (0.4–1.7) 0.8 (0.3–1.7) 0.8 (0.3–1.9)
Table 5
Odds ratio of high (Z90%) and low (r10%) adiponectin (mg/mL) and prenatal exposure to quartiles of maternal blood metals (MIREC study, 2008–2011) (n¼1258).
Contaminant Low adiponectin High adiponectin
Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95% CI) Unadjusted OR (95% CI) Adjusted ORa (95% CI) Adjusted ORb (95% CI)
Lead (mg/dL)
r0.63 1.0 1.0 1.0 1.0 1.0 1.0
0.64 to r0.87 1.3 (0.8–2.2) 1.3 (0.8–2.2) 1.3 (0.8–2.2) 0.9 (0.5–1.5) 0.8 (0.5–1.4) 0.9 (0.5–1.5)
0.88 to r1.20 0.9 (0.5–1.6) 0.9 (0.5–1.5) 0.8 (0.5–1.4) 1.1 (0.7–0.9) 1.0 (0.6–1.7) 1.1 (0.7–1.9)
41.20 1.1 (0.6–1.9) 1.1 (0.7–1.9) 1.1 (0.6–1.9) 0.8 (0.5–1.4) 0.8 (0.5–1.3) 0.9 (0.5–1.5)
Arsenic (mg/L)
r0.77 1.0 1.0 1.0 1.0 1.0 1.0
0.78 to r1.13 0.8 (0.5–1.4) 0.8 (0.5–1.3) 0.8 (0.5–1.3) 0.9 (0.5–1.5) 0.8 (0.5–1.3) 0.8 (0.5–1.3)
1.14 to r1.72 0.8 (0.5–1.4) 0.8 (0.5–1.4) 0.8 (0.5–1.3) 1.0 (0.6–1.6) 1.0 (0.6–1.6) 1.0 (0.6–1.7)
41.72 0.9 (0.5–1.5) 1.0 (0.6–1.6) 0.9 (0.6–1.6) 0.9 (0.5–1.5) 0.9 (0.5–1.5) 0.9 (0.5–1.6)
Mercury (mg/L)
r0.46 1.0 1.0 1.0 1.0 1.0 1.0
0.47 to r0.99 0.9 (0.5–1.5) 0.9 (0.5–1.6) 0.9 (0.5–1.6) 1.1 (0.6–1.9) 1.0 (0.6–1.7) 1.0 (0.6–1.7)
1.0 to r1.86 1.1 (0.7–1.9) 1.3 (0.8–2.1) 1.2 (0.7–2.1) 1.2 (0.7–2.1) 1.1 (0.6–1.8) 1.1 (0.6–1.9)
41.86 0.9 (0.5–1.5) 1.0 (0.6–1.7) 0.9 (0.5–1.6) 1.2 (0.7–2.1) 1.1 (0.6–1.8) 1.2 (0.7–2.0)
Cadmium (mg/L)
r0.20 1.0 1.0 1.0 1.0 1.0 1.0
0.21 to r0.29 1.0 (0.6–1.7) 1.0 (0.6–1.7) 1.0 (0.6–1.7) 0.8 (0.5–1.4) 0.7 (0.4–1.2) 0.7 (0.4–1.2)
0.30 to r0.44 0.9 (0.5–1.5) 0.9 (0.5–1.5) 0.9 (0.5–1.5) 1.0 (0.6–1.6) 0.8 (0.5–1.4) 0.8 (0.5–1.4)
40.44 0.8 (0.5–1.3) 0.8 (0.4–1.3) 0.8 (0.4–1.3) 1.0 (0.6–1.6) 0.9 (0.6–1.6) 1.0 (0.6–1.6)
a Adjusted for maternal age, education.
b Adjusted for maternal age, education, birth weight z-score.
Fig. 1. LOESS plot of association between log10 maternal cadmium and log10 cord
blood leptin.
Fig. 2. LOESS plot of association between log10 maternal lead and log10 cord blood
leptin.
J. Ashley-Martin et al. / Environmental Research 136 (2015) 27–3432skeletal growth. On the other hand, the observed ﬁnding in the
present study suggests that lead may be positively associated with
leptin, a surrogate of fat mass. Thus, it is possible that lead impacts
fetal growth through two different and potentially opposing
pathways. Further work is necessary to clarify and conﬁrm the
biological mechanisms underlying these potential pathways. Ad-
justment for birth weight was the best available measure in the
present study to determine whether the effect of lead on leptin
levels was independent of skeletal growth. This approach, how-
ever, is limited by the fact that birth weight encompasses both fat
mass and skeletal growth. Future investigations that can adjust
solely for skeletal growth will offer an even further reﬁned ability
to disentangle the relationships between lead and fetal fat mass.
Moreover, considering that the median levels (0.87 mg/dL) of lead
in the MIREC study are notably lower than the Health Canada
blood intervention level of 10 mg/dL (Health Canada, 2013), anylead-related effects on fetal growth and development may be
more pronounced in populations with high levels of exposure.
We did not identify any association between either arsenic or
mercury and the adipokines. Though comparisons are difﬁcult due
to the difference in exposure medium, a Bangladesh birth cohort
study reported an inverse association between prenatal urinary
arsenic levels and birth weight, chest and head circumferences at
maternal urinary arsenic levels below 100 mg/L. Exposure levels
greater than this threshold, however, were not associated with any
effect (Rahman et al., 2009). The literature on prenatal mercury
exposure and fetal growth is limited and inconsistent. A French
birth cohort study (EDEN) reported no association between pre-
natal mercury and fetal growth in the entire study population
though a positive association between mercury levels and birth
weight were seen among overweight women (Drouillet-Pinard
et al., 2010). A Viennese study similarly identiﬁed no association
between maternal mercury levels and birth weight yet was limited
J. Ashley-Martin et al. / Environmental Research 136 (2015) 27–34 33by low sample size (Gundacker et al., 2010). And, a Spanish birth
cohort reported both positive and inverse associations between
mercury and ﬁsh consumption and SGA depending on the type
and amount of ﬁsh consumed (Ramon et al., 2009).
In addition to the differences in metal measurement techniques
and study populations, the discrepancy between our ﬁndings and
previous birth cohort studies may be explained by the difference
in outcome measures. The present examination of cord blood
adipokine levels has facilitated examination of the effects of ma-
ternal blood metal levels on neonatal endocrine and metabolic
development. Further investigation of this cohort is necessary to
understand how fetal leptin and adiponectin translate into child-
hood growth trajectories. Leptin levels at birth have been found to
be correlated with anthropometric measures in childhood (Kar-
akosta and Chatzi, 2011; Mantzoros et al., 2009); the relationship
between adiponectin and BMI is more complicated (Mazaki-Tovi
et al., 2005; Volberg et al., 2013). Though birth weight is positively
correlated with cord blood adiponectin, adiponectin levels are low
in obese adults (Mazaki-Tovi et al., 2005).
This longitudinal cohort study was able to assess the relation-
ship between maternal metal concentrations and cord blood levels
of leptin and adiponectin using biomonitoring data from a trans-
Canada cohort of study participants. The sample size in this study
exceeds many of the previous analyses of the potential health ef-
fects of metals in birth cohort studies. Blood metal concentrations
were analyzed in the ﬁrst and third trimesters thus allowing us to
calculate an average exposure index over the duration of preg-
nancy with a minimal amount of missing data. The comprehensive
questionnaire data available in the MIREC study allowed us to
control for key confounders such as smoking, maternal pre-preg-
nancy BMI, and parity.
Despite these strengths, our study was subject to limitations
common to observational studies. First, though the MIREC study
had a rich set of covariate data, the role of residual confounding
cannot be ruled out. For instance, nutritional and iron status was
not available. Second, due to the number of chemicals and out-
comes tested, the possibility of identifying a signiﬁcant association
by chance cannot be dismissed. Lastly, the MIREC study population
is on average from a higher socioeconomic status, lower BMI, and
less likely to smoke than the general population. Thus, caution is
warranted in generalizing these ﬁndings to the population at large.5. Conclusions
In conclusion, the observed relationships between lead and
cadmium and fetal leptin levels suggest that prenatal exposure to
elevated levels of these metals may impact fetal metabolic de-
velopment. These ﬁndings contribute to the growing body of
evidence demonstrating the susceptibility of fetal development to
exogenous chemical exposures and the multifactorial etiology of
childhood growth trajectories (Keith et al., 2006; Cunningham
et al., 2014; Warrington et al., 2013). Future follow up in this co-
hort will facilitate examination of the relationship between pre-
natal metal exposure, fetal adipokine levels, and anthropometric
measures in childhood.Acknowledgements
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